Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by Valion Bio, Inc.
Valion Bio and Shear Kershman Laboratories Successfully Formulate Oral Mucosal Entolimod; Valion Sees Potential for Multi-Fold Expansion of Long-Term Opportunity
Today 7:45 EDT
From
Valion Bio, Inc.
Via
ACCESS Newswire
Tickers
VBIO
Valion Appoints Life Sciences Veteran Dean Zikria as Interim CEO and Announces Board Leadership Transitions
September 23, 2026
From
Valion Bio, Inc.
Via
ACCESS Newswire
Tickers
VBIO
Valion Bio Regains Compliance with NASDAQ Minimum Bid Price Listing Rule
September 22, 2026
From
Valion Bio, Inc.
Via
ACCESS Newswire
Tickers
VBIO
Valion Bio Announces Changes to Management and Board of Directors
September 01, 2026
From
Valion Bio, Inc.
Via
ACCESS Newswire
Tickers
VBIO
Valion Bio Announces Reverse Stock Split
August 27, 2026
From
Valion Bio, Inc.
Via
ACCESS Newswire
Tickers
VBIO
Ukraine's Ministry Of Health Advances Entolimod Review Into Technical Assessment Phase
August 13, 2026
From
Valion Bio, Inc.
Via
ACCESS Newswire
Tickers
VBIO
Valion Bio Announces U.S. Government-Funded Entolimod Studies Targeting Lethal Radiation-Induced GI Injury
August 12, 2026
From
Valion Bio, Inc.
Via
ACCESS Newswire
Tickers
VBIO
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.